Table 1 Demographic, imaging, and clinical data of study patients
Variables | Total (n = 44) | Alive (n = 38) | Deceased (n = 6) | P-value |
|---|---|---|---|---|
Male | 23 (52.3%) | 19 (50%) | 4 (66.7%) | 0.448 |
Age (mean ± SD) | 64.3 ± 10.6 | 63.4 ± 11 | 69.8 ± 5.3 | 0.168 |
Right-sided weakness | 24 (54.5%) | 21 (55.3%) | 3 (50%) | 0.810 |
Aphasia | 24 (54.5%) | 21 (55.3%) | 3 (50%) | 0.810 |
Gaze palsy | 38 (86.4%) | 33 (86.8%) | 5 (83.3%) | 0.816 |
Time from symptom onset to femoral arterial puncture in min (mean ± SD) | 304.1 ± 60.9 | 300.8 ± 61.8 | 325 ± 55 | 0.372 |
NIHSS at presentation (mean ± SD) | 19.2 ± 3.5 | 18.7 ± 3.2 | 22.2 ± 3.8 | 0.021 |
Blood glucose at admission | 146.7 ± 54.7 | 144.7 ± 55.6 | 159.2 ± 51.6 | 0.554 |
Baseline MAP (mean ± SD) | 99.3 ± 10.5 | 99.6 ± 9.6 | 97.5 ± 16.2 | 0.649 |
History of HTN | 24 (54.5%) | 19 (50%) | 5 (83.3%) | 0.128 |
History of DM | 20 (45.5%) | 17 (44.7%) | 3 (50%) | 0.810 |
History of IHD | 11 (25%) | 10 (26.3%) | 1 (16.7%) | 0.612 |
AF | 7 (15.9%) | 7 (18.4%) | 0 (0%) | 0.252 |
Rheumatic heart disease | 2 (4.5%) | 2 (5.3%) | 0 (0%) | 0.565 |
Dyslipidemia | 10 (22.7%) | 9 (23.7%) | 1 (16.7%) | 0.703 |
Smoking | 16 (36.4%) | 12 (31.6%) | 4 (66.7%) | 0.097 |
BMI | 31.6 ± 4.6 | 31.7 ± 4.6 | 30.8 ± 55.3 | 0.679 |
ASPECT score (mean ± SD) | 9.3 ± 1.1 | 9.5 ± 1.1 | 9 ± 1.1 | 0.266 |
Site of occlusion | 0.134 | |||
MCA M1 | 24 (54.5%) | 23 (60.5%) | 1 (16.7%) | |
ICA | 4 (9.1%) | 3 (7.9%) | 1 (16.7%) | |
MCA and ICA | 16 (36.4%) | 12 (31.6%) | 4 (66.7%) |